Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_assertion type Assertion NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_head.
- NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_assertion description "[The BCR-ABL-negative myeloproliferative neoplasms (MPNs), polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF), entered the spotlight in 2005 when the unique somatic acquired JAK2 V617F mutation was described in >95% of PV and in 50% of ET and PMF patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_provenance.
- NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_assertion evidence source_evidence_literature NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_provenance.
- NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_assertion SIO_000772 18769448 NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_provenance.
- NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_assertion wasDerivedFrom befree-2016 NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_provenance.
- NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_assertion wasGeneratedBy ECO_0000203 NP691451.RAnr1uOWGTBsWD-wsgWK86qHzJWI8UiqsYbdp-cYnRDEk130_provenance.